Immediate Impact
4 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Biomarker-driven molecular imaging probes in radiotherapy
2024 Standout
Works of Gemma Sheehan‐Dare being referenced
The PRIMARY Score: Using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis.
2022
64Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I Trial
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gemma Sheehan‐Dare | 36 | 41 | 73 | 6 | 107 | |
| Kristen Curtis | 28 | 33 | 69 | 10 | 82 | |
| J. Calvert | 20 | 39 | 67 | 5 | 85 | |
| Clive Hayward | 24 | 18 | 38 | 6 | 175 | |
| T Do | 27 | 46 | 83 | 8 | 181 | |
| Shaojun Zhu | 40 | 76 | 71 | 7 | 103 | |
| Salvador Villà Freixa | 33 | 9 | 61 | 5 | 88 | |
| Lucy Samoilov | 36 | 101 | 155 | 5 | 183 | |
| Mauricio Serra | 25 | 20 | 108 | 6 | 189 | |
| Ihor Sawczuk | 56 | 14 | 82 | 7 | 113 | |
| Drew C. Monitto | 29 | 20 | 160 | 6 | 184 |
All Works
Login with ORCID to disown or claim papers
Loading papers...